tirzepatide obesity nejm In the SUMMIT trial, researchers examined cardiovascular outcomes of treatment with in patients with heart failure with preserved ejection fraction and obesity. Full trial results and Plain Language Summary: https://t.co/8joe2mst3e Tirzepatide vs Semaglutide: 2025 NEJM

Folate: Fact sheet for health professionals

What GLP-1 therapies do, and why the mouth sometimes notices GLP-1 (glucagon-like peptide-1) is a gut hormone that helps regulate appetite, digestion, and blood sugar

OASIS 4: Oral Semaglutide 25mg for Obesity

While these effects can be bothersome, they are generally mild and often resolve as the body adjusts to the medication

For instance, oral administration of LA loaded into thermally hydrocarbonized porous silicon (THCPSi) particles stimulated GLP1 release via GPR120 in a sustained manner and inhibited the food intake in mice [155] (Fig

This reaction makes it a potential treatment for type 2 diabetes